Percentage of rheumatologists in the 3E Initiative who indicated for each recommendation if it would change their clinical practice
| Recommendation (number and topic) | The recommendation will change my practice (%) | The recommendation is already my practice (%) | I don't want to change my practice for this aspect (%) |
|---|---|---|---|
| 1. Pre-UPIA differential diagnosis and investigations | 0 | 96.5 | 3.5 |
| 2. History and physical examination | 0 | 98.3 | 1.8 |
| 3. Acute phase reactants | 5.4 | 91.1 | 3.6 |
| 4. Autoantibodies | 1.8 | 96.4 | 1.8 |
| 5. X-rays | 16.1 | 48.2 | 35.7 |
| 6. MRI and ultrasound | 17.9 | 64.3 | 17.9 |
| 7. Genetic markers | 1.8 | 92.9 | 5.4 |
| 8. Synovial biopsy | 8.9 | 83.9 | 7.1 |
| 9. Predictors of persistence (chronicity) | 24.6 | 66.7 | 8.8 |
| 10. Measures of clinical disease activity | 12.3 | 84.2 | 3.5 |
UPIA, undifferentiated peripheral inflammatory arthritis.